Determining the Factors Predicting the Success of Medical Management in Patients with Ectopic Pregnancy

Medical management in patients with ectopic pregnancy

Authors

  • Ayda Roostaee Department of Radiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Zeinab Safarpour lima Department of Radiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Sima Sharif Kazemi Department of Radiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Ghazaleh Dezyani Department of Radiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Seyed Taleb Pourseyedian Department of Radiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.31661/gmj.vi.3761

Keywords:

Ectopic Pregnancy; Methotrexate; Human Chorionic Gonadotropin Hormone

Abstract

Bachground: Ectopic pregnancy is considered the most common cause of pregnancy-related deaths in the first trimester. Methotrexate is recognized as an effective drug for the treatment of ectopic pregnancy. The aim of this study was to determine the associated and predictive factors for success in medical treatment among patients with ectopic pregnancy (EP). Materials and Methods: After collection of Demographic information, serum β-hCG levels and ultrasound findings were evaluated and compared between two groups: those with successful medical treatment and those without. Results: The mean β-hCG level have not significant difference between the two groups (P=0.806). The frequency of previous IUD use in the successful treatment group was 8%, while there were no cases in the failure group; however, this difference was not statistically significant (P=0.547). The frequency of prior EP, the observed frequency of hematoma and the frequency of tubal ring observation, which also showed no significant difference (respectively P=0.9, P=0.9 and P=0.111). Logistic regression analysis revealed that none of the investigated variables were significant predictors of treatment success. However, the presence of a tubal ring (OR: 6.500, 95% CI: 0.799–52.897, p = 0.080) and increased endometrial thickness (OR: 1.317, 95% CI: 0.971–1.786, p = 0.077) showed borderline significance. Commonly considered factors, such as gestational age, β-hCG levels, patient age, parity, and gravidity, did not significantly influence treatment success. The study highlights a high success rate for single-dose methotrexate therapy and the potential utility of tubal ring and endometrial thickness as clinical indicators, warranting further investigation. Conclusion: The results of this study indicate that single-dose methotrexate treatment for tubal ectopic pregnancy leads to a high success rate. Given the sample size of this study, none of the variables had a significant impact on treatment success or predictive power.

References

Lin EP, Bhatt S, Dogra VS. Diagnostic clues to ectopic pregnancy. Radiographics. 2008;28(6):1661-71.

https://doi.org/10.1148/rg.286085506

PMid:18936028

Di Gennaro D, Damiani GR, Muzzupapa G, Stomati M, Cicinelli R, Gaetani M et al. Ectopic pregnancy: An overview. Clinical and Experimental Obstetrics & Gynecology. 2022;49(12):262.

https://doi.org/10.31083/j.ceog4912262

American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 193: tubal ectopic pregnancy. Obstetrics and gynecology. 2018 Mar;131(3):e91-103.

https://doi.org/10.1097/AOG.0000000000002560

Tsakiridis I, Giouleka S, Mamopoulos A, Athanasiadis A, Dagklis T. Diagnosis and management of ectopic pregnancy: a comparative review of major national guidelines. Obstetrical & gynecological survey. 2020;75(10):611-23.

https://doi.org/10.1097/OGX.0000000000000832

PMid:33111962

Li C, Zhao W-H, Zhu Q, Cao S-J, Ping H, Xi X et al. Risk factors for ectopic pregnancy: a multi-center case-control study. BMC pregnancy and childbirth. 2015;15:1-9.

https://doi.org/10.1186/s12884-015-0613-1

PMid:26296545 PMCid:PMC4546260

Ranji GG, Usha Rani G, Varshini S. Ectopic pregnancy: risk factors, clinical presentation and management. The Journal of Obstetrics and Gynecology of India. 2018;68:487-92.

https://doi.org/10.1007/s13224-017-1075-3

PMid:30416277 PMCid:PMC6207546

Houser M, Kandalaft N, Khati NJ. Ectopic pregnancy: a resident's guide to imaging findings and diagnostic pitfalls. Emergency radiology. 2022 Feb 1:1-2.

https://doi.org/10.1007/s10140-021-01974-7

PMid:34618256

Cheng LY, Lin PY, Huang FJ, Kung FT, Chiang HJ, Lin YJ, Lan KC. Ectopic pregnancy following in vitro fertilization with embryo transfer: A single-center experience during 15 years. Taiwan J Obstet Gynecol. 2015;54(5):541-5.

https://doi.org/10.1016/j.tjog.2015.08.004

PMid:26522107

WHO. Caesarean section rates continue to rise, amid growing inequalities in access,. 3 December 2022. https://www.who.int/news/item/16-06-2021-caesarean-section-rates-continue-to-rise-amid-growing-inequalities-in-access. Accessed 3 December 2022.

Obeagu EI, Faduma MH, Uzoma G. Ectopic Pregnancy: A Review. Int J Curr Res Chem Pharm Sci. 2023;10(4):40-4.

https://doi.org/10.22270/ijmspr.v10i4.123

Cecchino GN, Araujo Júnior E, Elito Júnior J. Methotrexate for ectopic pregnancy: when and how. Archives of gynecology and obstetrics. 2014;290:417-23.

https://doi.org/10.1007/s00404-014-3266-9

PMid:24791968

Stovall DW, Van Voorhis BJ, Sparks AE, Adams LM, Syrop CH. Selective early elimination of luteal support in assisted reproduction cycles using a gonadotropin-releasing hormone agonist during ovarian stimulation. Fertility and sterility. 1998;70(6):1056-62.

https://doi.org/10.1016/S0015-0282(98)00356-2

PMid:9848295

Tanaka T. Treatment of interstitial ectopic pregnanacy with methotrexate: report of a successful case. Fertil steril. 1982;37:851-2.

https://doi.org/10.1016/S0015-0282(16)46349-1

PMid:7084507

Bottin P, Gnisci A, Crochet P, Butzbach P, Cravello L, Gamerre M, Agostini A. Prognostic value of early hCG changes after methotrexate injection for ectopic pregnancy. Gynecologie, Obstetrique & Fertilite. 2013;42(1):3-7.

https://doi.org/10.1016/j.gyobfe.2013.08.006

PMid:24309031

Ghanaie MM, Hoshyarmanesh S, Asgari SM, Galebin SMA, Fakor F. Predictive value of serum βHCG level in ectopic pregnancy: A cross sectional study. Health Science Reports. 2023;6(9):e1442.

https://doi.org/10.1002/hsr2.1442

PMid:37680207 PMCid:PMC10480407

Mirbolouk F, Yousefnezhad A, Ghanbari A. Predicting factors of medical treatment success with single dose methotrexate in tubal ectopic pregnancy: a retrospective study. Iranian journal of reproductive medicine. 2015;13(6):351.

Chegini V, Pakniat H, Shora M, Mirzadeh M, Lalooha F, Griffiths M, Alimoradi Z. Predictors of single-dose methotrexate treatment success in ectopic pregnancies: A retrospective cohort study. Clínica e Investigación en Ginecología y Obstetricia. 2024;51(4):100967.

https://doi.org/10.1016/j.gine.2024.100967

Abdelfattah-Arafa E, Abdussalam HF, Omar Saad M, El Ansari W. The predictors of successful methotrexate treatment of tubal ectopic pregnancy. Journal of Obstetrics and Gynaecology. 2024;44(1):2361456.

https://doi.org/10.1080/01443615.2024.2361456

PMid:38864434

Bonin L, Pedreiro C, Moret S, Chene G, Gaucherand P, Lamblin G. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2017;208:23-30.

https://doi.org/10.1016/j.ejogrb.2016.11.016

PMid:27888702

Shatkin Hamish N, Wolf M, Tendler R, Sharon A, Bornstein J, Odeh M. Early prediction of methotrexate treatment outcome in tubal ectopic pregnancy based on days 0 and 4 human chorionic gonadotropin levels. Journal of Obstetrics and Gynaecology Research. 2020;46(7):1104-9.

https://doi.org/10.1111/jog.14259

PMid:32406562

Deniz S, Ali B, Canan U, Yılmaz AH, Olcay I, Burcu D, Fatma GK. Evaluation of the parameters in predicting single‐dose methotrexate therapy success for ectopic pregnancy. Journal of Obstetrics and Gynaecology Research. 2024;50(5):856-63.

https://doi.org/10.1111/jog.15923

PMid:38476034

Liu J, Kong H, Yu X, Zhou M, Liu X, Liu X et al. The role of endometrial thickness in predicting ectopic pregnancy after in vitro fertilization and the establishment of a prediction model. Front Endocrinol (Lausanne). 2022;13:895939. doi:10.3389/fendo.2022.895939.

https://doi.org/10.3389/fendo.2022.895939

PMid:36157457 PMCid:PMC9493494

Downloads

Published

2025-06-29

How to Cite

Roostaee, A., Safarpour lima, Z., Sharif Kazemi, S., Dezyani, G., & Pourseyedian, S. T. (2025). Determining the Factors Predicting the Success of Medical Management in Patients with Ectopic Pregnancy: Medical management in patients with ectopic pregnancy. Galen Medical Journal, e3761. https://doi.org/10.31661/gmj.vi.3761

Issue

Section

Original Article